PYC vs. EVG, NFX, FAB, APTA, OVB, OCTP, IXI, VAL, BSFA, and ROQ
Should you be buying Physiomics stock or one of its competitors? The main competitors of Physiomics include Evgen Pharma (EVG), Nuformix (NFX), Fusion Antibodies (FAB), Aptamer Group (APTA), Ovoca Bio (OVB), Oxford Cannabinoid Technologies (OCTP), IXICO (IXI), ValiRx (VAL), BSF Enterprise (BSFA), and Roquefort Therapeutics (ROQ). These companies are all part of the "biotechnology" industry.
Physiomics (LON:PYC) and Evgen Pharma (LON:EVG) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, valuation, risk, media sentiment, dividends, community ranking, profitability and analyst recommendations.
Evgen Pharma received 113 more outperform votes than Physiomics when rated by MarketBeat users. Likewise, 74.23% of users gave Evgen Pharma an outperform vote while only 55.56% of users gave Physiomics an outperform vote.
Evgen Pharma has a net margin of 0.00% compared to Physiomics' net margin of -70.32%. Evgen Pharma's return on equity of -60.57% beat Physiomics' return on equity.
0.1% of Physiomics shares are held by institutional investors. Comparatively, 27.8% of Evgen Pharma shares are held by institutional investors. 6.3% of Physiomics shares are held by company insiders. Comparatively, 32.4% of Evgen Pharma shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
In the previous week, Physiomics' average media sentiment score of 0.00 equaled Evgen Pharma'saverage media sentiment score.
Physiomics has higher revenue and earnings than Evgen Pharma.
Physiomics has a beta of 1.78, indicating that its share price is 78% more volatile than the S&P 500. Comparatively, Evgen Pharma has a beta of 1.44, indicating that its share price is 44% more volatile than the S&P 500.
Summary
Evgen Pharma beats Physiomics on 6 of the 10 factors compared between the two stocks.
Get Physiomics News Delivered to You Automatically
Sign up to receive the latest news and ratings for PYC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Physiomics Competitors List
Related Companies and Tools
